Zheng, Haoyang http://orcid.org/0000-0001-6835-8242
Petrella, Jeffrey R. http://orcid.org/0000-0003-2596-217X
Doraiswamy, P. Murali
Lin, Guang http://orcid.org/0000-0002-0976-1987
Hao, Wenrui
,
Funding for this research was provided by:
NSF | Directorate for Mathematical & Physical Sciences | Division of Mathematical Sciences (DMS-1736364, DMS-2134209, DMS-2053746, DMS-2052676, DMS-2052685)
NSF | Directorate for Mathematical & Physical Sciences | Division of Mathematical Sciences
NSF | Directorate for Mathematical & Physical Sciences | Division of Mathematical Sciences
DOE | Office of Science (DE-SC0021142)
NSF | Directorate for Mathematical & Physical Sciences | Division of Mathematical Sciences
NSF | Directorate for Mathematical & Physical Sciences | Division of Mathematical Sciences
Article History
Received: 18 December 2021
Accepted: 16 June 2022
First Online: 8 September 2022
Competing interests
: The authors declare no Competing Non-Financial Interests but the following Competing Financial Interests: PMD is a co-inventor on patents for the diagnosis or treatment of Alzheimer disease. PMD owns shares in several biotechnology companies whose products are not discussed here. P.M.D. has received grants from NIH, DARPA, DOD, ONR, Bausch, Avanir, Avid, Cure Alzheimer’s Fund, Karen L. Wrenn Trust, Steve Aoki Foundation, and advisory fees from Apollo, Brain Forum, Clearview, Lumos, Neuroglee, Otsuka, Verily, Vitakey, Sermo, Lilly, Vivly, and Transposon.